Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III long-term study of M605101 in patients with acne vulgaris
jRCT2080221864Phase 3
- Sponsor
- Maruho Co., Ltd.
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of trifarotene in acne vulgaris, sponsored by Maruho Co., Ltd.
02
Drugs
trifarotene
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on jRCT2080221864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221864.